LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro

Characteristics of Glucose Metabolism in Nordic and South Asian Subjects with Type 2 Diabetes

(2014) Cecilie Wium et al.   PLoS One

Circulating Dickkopf‐1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low‐Dose Aspirin

(2014) Stefano Lattanzio et al.   Journal of the American Heart Association

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

(2013) Steven E Kahn et al.   LANCET

Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: Reduction with weight loss

(2013) Paresh Dandona et al.   Obesity

How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes

(2012) Marianne Böni-Schnetzler et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer

(2011) Wan-Wan Lin et al.   BIOCHEMICAL PHARMACOLOGY

LIGHT/TNFSF14 enhances adipose tissue inflammatory responses through its interaction with HVEM

(2011) Hong-Min Kim et al.   FEBS LETTERS

Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice

(2010) Yoonjung Park et al.   BASIC RESEARCH IN CARDIOLOGY

DcR3 Protects Islet   Cells from Apoptosis through Modulating Adcyap1 and Bank1 Expression

(2009) B. Han et al.   JOURNAL OF IMMUNOLOGY

Characterization of Herpes Virus Entry Mediator as a Factor Linked to Obesity

(2009) Judit Bassols et al.   Obesity

Inflammatory Interaction Between LIGHT and Proteinase-Activated Receptor-2 in Endothelial Cells

(2008) Wiggo J. Sandberg et al.   CIRCULATION RESEARCH

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

(2008) Theodore Mazzone et al.   LANCET